An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.

MLA

Oh, J., et al. “An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, Nov. 2020, p. S62. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2020.07.2194.

APA

Oh, J., Tyldesley, S., Pai, H. H., McKenzie, M. R., Halperin, R. M., Duncan, G. G., Morton, G., Keyes, M., Hamm, J., & Morris, W. J. (2020). An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 108(3), S62. https://doi.org/10.1016/j.ijrobp.2020.07.2194

Chicago

Oh, J., S. Tyldesley, H.H. Pai, M.R. McKenzie, R.M. Halperin, G.G. Duncan, G. Morton, M. Keyes, J. Hamm, and W.J. Morris. 2020. “An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics 108 (3): S62. doi:10.1016/j.ijrobp.2020.07.2194.